Inhibikase Therapeutics (IKT) Stock Insights
$223.26M
Market Cap
-3.35
P/E
6.60
Forward P/E
68
Score
IKT price $1.60 +0.03 +1.91%
Stocklytics score rationale: value 57, quality 48, growth 100.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 967386 | 2060937 | 4040955 | 1122740 | 698468 | 3100605 | 123440 | 260500 | 0 | 0 |
Inhibikase Therapeutics, Inc. operates as a clinical-stage pharmaceutical company that develops therapeutics to modify the course of cardiopulmonary diseases, with a primary focus on pulmonary arterial hypertension (PAH), a progressive, life-threatening disease characterized by pulmonary vascular remodeling and elevated pulmonary vascular resistance. It offers IKT-001, a novel oral prodrug of imatinib mesylate…
IKT fair value $5.24. Price $1.60. Price is 69% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 26.48K. Growth 3.13%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.24% (beta 0.9). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 139.54M. Net debt -139.22M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-13 | — | -0.11 | — | 187.50K |
| 2026-08-11 | -0.11 | -0.11 | — | — |
| 2026-05-12 | -0.10 | -0.10 | — | — |
| 2026-03-26 | -0.09 | -0.12 | — | — |
| 2025-11-14 | -0.13 | -0.13 | — | — |
| 2025-08-14 | -0.11 | -0.09 | — | — |
| 2025-05-14 | -0.15 | -0.11 | — | — |
| 2025-03-27 | 0.88 | -0.10 | — | — |
| 2024-11-14 | -0.65 | -0.38 | — | — |
| 2024-08-14 | -0.66 | -0.58 | — | — |
| 2024-05-15 | -0.73 | -0.79 | — | — |
| 2024-03-27 | -0.63 | -0.78 | 1 | — |
| 2023-11-14 | -0.86 | -1.12 | 79.57K | — |
| 2023-08-14 | -1.11 | -0.92 | 116.41K | — |
| 2023-05-16 | -0.96 | -0.15 | 64.52K | — |
| 2023-03-31 | -1.02 | -1.14 | 53.44K | — |
| 2022-11-14 | -1.08 | -0.18 | 7.29K | 200.00K |
| 2022-08-12 | -1.08 | -0.19 | 6.55K | 300.00K |
| 2022-05-16 | -1.08 | -0.17 | 46.03K | 300.00K |
| 2022-03-31 | -1.20 | -0.17 | 1.94K | 300.00K |
| 2021-11-15 | -1.08 | -0.14 | 328.46K | 300.00K |
| 2021-08-16 | -1.32 | -0.38 | 1.36M | 300.00K |
| 2021-05-17 | -1.56 | — | 1.41M | — |
| 2021-03-31 | -0.87 | — | 698.47K | — |
| 2020-09-30 | -0.49 | — | 37.68K | — |
| 2020-06-30 | -0.31 | — | 219.59K | — |
| 2020-03-31 | -0.40 | — | 270.79K | — |
| 2019-12-31 | -0.32 | — | 240.28K | — |
| 2019-09-30 | -0.89 | — | 124.43K | — |
| 2019-06-30 | -1.72 | — | 166.93K | — |
| 2019-03-31 | -1.27 | — | 591.10K | — |
| 2018-12-31 | -0.74 | — | 1.35M | — |
| 2018-03-31 | -0.10 | — | 691.20K | — |
| 2017-12-31 | 0.03 | — | 797.40K | — |
| 2017-03-31 | -0.14 | — | 247.38K | — |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-19 | Wasserman Scott M. | Buy | 310.00K | $1.65 | 509.95K |
| 2026-10-19 | Wasserman Scott M. | Other | 0 | — | — |
| 2026-07-30 | BERMAN DENNIS N | Buy | 21.85K | $1.26 | 27.54K |
| 2026-07-30 | BERMAN DENNIS N | Sell | 21.85K | $1.26 | 27.54K |
| 2026-07-29 | RA CAPITAL MANAGEMENT, L.P. | Buy | 18.03M | $0.00 | 18.03K |
| 2026-07-29 | RA CAPITAL MANAGEMENT, L.P. | Sell | 18.03M | $0.00 | 18.03K |
| 2026-07-10 | RA CAPITAL MANAGEMENT, L.P. | Other | 0 | — | — |
| 2026-06-26 | BERMAN DENNIS N | Buy | 155.00K | $1.91 | 296.05K |
| 2026-06-26 | Canner David | Buy | 155.00K | $1.91 | 296.05K |
| 2026-06-26 | Kush Arvind | Buy | 155.00K | $1.91 | 296.05K |
| 2026-06-26 | Bellini Roberto | Buy | 155.00K | $1.91 | 296.05K |
| 2026-06-26 | Aurentz Vincent | Buy | 155.00K | $1.91 | 296.05K |
| 2026-06-26 | Munshi Amit | Buy | 155.00K | $1.91 | 296.05K |
| 2026-02-21 | Aurentz Vincent | Sell | 255.30K | — | — |
| 2026-02-21 | Cabell Christopher | Sell | 338.28K | — | — |
| 2026-02-21 | Munshi Amit | Sell | 19.09K | — | — |
| 2026-01-05 | Iwicki Mark T | Buy | 4.98M | $2.01 | 10.02M |
| 2026-01-05 | Cabell Christopher | Buy | 900.12K | $2.01 | 1.81M |
| 2026-01-05 | McIntyre David | Buy | 986.32K | $2.01 | 1.98M |
| 2025-11-21 | Sands Capital Life Sciences Pulse Fund II, L.P. | Buy | 2.07M | $1.45 | 3.00M |
| 2025-06-30 | Aurentz Vincent | Buy | 108.18K | $1.95 | 210.94K |
| 2025-06-30 | Canner David | Buy | 108.18K | $1.95 | 210.94K |
| 2025-06-30 | Munshi Amit | Buy | 108.18K | $1.95 | 210.94K |
| 2025-06-30 | Kush Arvind | Buy | 108.18K | $1.95 | 210.94K |
| 2025-06-30 | BERMAN DENNIS N | Buy | 108.18K | $1.95 | 210.94K |
| 2025-06-30 | Bellini Roberto | Buy | 108.18K | $1.95 | 210.94K |
| 2025-06-06 | Sands Capital Life Sciences Pulse Fund II, L.P. | Other | 0 | — | — |
| 2025-04-14 | McIntyre David | Buy | 1.78M | $2.00 | 3.55M |
| 2025-04-14 | McIntyre David | Other | 0 | — | — |
| 2025-02-21 | Cabell Christopher | Other | 0 | — | — |
| 2025-02-21 | Aurentz Vincent | Other | 0 | — | — |
| 2025-02-21 | Munshi Amit | Buy | 57.27K | — | — |
| 2025-02-21 | Cabell Christopher | Buy | 1.10M | $2.97 | 3.27M |
| 2025-02-21 | Iwicki Mark T | Buy | 602.35K | $2.97 | 1.79M |
| 2025-02-21 | Aurentz Vincent | Buy | 134.43K | $2.97 | 399.25K |
| 2025-02-21 | Cabell Christopher | Buy | 1.10M | $2.23 | 2.45M |
| 2025-02-21 | Aurentz Vincent | Buy | 134.43K | $2.23 | 299.77K |
| 2025-02-21 | Iwicki Mark T | Buy | 602.35K | $2.23 | 1.34M |
| 2025-02-21 | Cabell Christopher | Other | 0 | — | — |
| 2025-02-21 | Aurentz Vincent | Other | 0 | — | — |
| 2025-02-17 | Iwicki Mark T | Buy | 1.79M | $2.35 | 4.22M |
| 2025-02-14 | Iwicki Mark T | Buy | 4.37M | $2.35 | 10.28M |
| 2025-02-14 | Iwicki Mark T | Other | 0 | — | — |
| 2025-02-14 | Kush Arvind | Buy | 116.58K | $2.35 | 273.97K |
| 2025-02-14 | Kush Arvind | Buy | 56.60K | $2.35 | 133.01K |
| 2025-02-14 | Bellini Roberto | Buy | 116.58K | $2.35 | 273.97K |
| 2025-02-14 | Bellini Roberto | Buy | 73.58K | $2.35 | 172.91K |
| 2025-02-14 | Freeman Roy Lester | Buy | 22.64K | $2.35 | 53.20K |
| 2025-02-14 | Munshi Amit | Buy | 116.58K | $2.35 | 273.97K |
| 2025-02-14 | Munshi Amit | Buy | 56.60K | $2.35 | 133.01K |
| 2025-02-14 | Canner David | Buy | 116.58K | $2.35 | 273.97K |
| 2025-02-14 | Canner David | Buy | 22.64K | $2.35 | 53.20K |
| 2025-02-14 | BERMAN DENNIS N | Buy | 39.62K | $2.35 | 93.11K |
| 2025-01-21 | Lees-Rolfe Garth | Buy | 90.00K | $1.26 | 113.40K |
| 2025-01-21 | Lees-Rolfe Garth | Buy | 5.83K | $1.26 | 7.35K |
| 2025-01-21 | Lees-Rolfe Garth | Sell | 90.00K | $2.16 | 194.40K |
| 2025-01-21 | Lees-Rolfe Garth | Sell | 5.83K | $3.79 | 22.11K |
| 2025-01-21 | Freeman Roy Lester | Buy | 30.00K | $1.26 | 37.80K |
| 2025-01-21 | Freeman Roy Lester | Buy | 21.85K | $1.26 | 27.54K |
| 2025-01-21 | Freeman Roy Lester | Buy | 6.67K | $1.26 | 8.40K |
| 2025-01-21 | Freeman Roy Lester | Buy | 3.78K | $1.26 | 4.76K |
| 2025-01-21 | Freeman Roy Lester | Buy | 1.14K | $1.26 | 1.43K |
| 2025-01-21 | Freeman Roy Lester | Sell | 6.67K | $3.61 | 24.07K |
| 2025-01-21 | Freeman Roy Lester | Sell | 21.85K | $33.43 | 730.58K |
| 2025-01-21 | Freeman Roy Lester | Sell | 1.14K | $60.00 | 68.28K |
| 2025-01-21 | Freeman Roy Lester | Sell | 3.78K | $17.52 | 66.23K |
| 2025-01-21 | Freeman Roy Lester | Sell | 6.67K | $4.86 | 32.40K |
| 2025-01-21 | Freeman Roy Lester | Sell | 30.00K | $1.54 | 46.20K |
| 2025-01-21 | Werner Milton H. | Buy | 45.00K | $1.26 | 56.70K |
| 2025-01-21 | Werner Milton H. | Buy | 35.00K | $1.26 | 44.10K |
| 2025-01-21 | BERMAN DENNIS N | Buy | 30.00K | $1.26 | 37.80K |
| 2025-01-21 | BERMAN DENNIS N | Buy | 21.85K | $1.26 | 27.54K |
| 2025-01-21 | Werner Milton H. | Buy | 20.83K | $1.26 | 26.25K |
| 2025-01-21 | Werner Milton H. | Buy | 16.67K | $1.26 | 21.00K |
| 2025-01-21 | BERMAN DENNIS N | Buy | 6.67K | $1.26 | 8.40K |
| 2025-01-21 | BERMAN DENNIS N | Buy | 3.78K | $1.26 | 4.76K |
| 2025-01-21 | Werner Milton H. | Buy | 3.64K | $1.26 | 4.59K |
| 2025-01-21 | BERMAN DENNIS N | Buy | 1.14K | $1.26 | 1.43K |
| 2025-01-21 | Werner Milton H. | Sell | 3.64K | $33.43 | 121.79K |
| 2025-01-21 | Werner Milton H. | Sell | 3.64K | $13.86 | 50.49K |
| 2025-01-21 | BERMAN DENNIS N | Sell | 21.85K | $33.43 | 730.58K |
| 2025-01-21 | Werner Milton H. | Sell | 35.00K | $4.44 | 155.40K |
| 2025-01-21 | BERMAN DENNIS N | Sell | 6.67K | $4.86 | 32.40K |
| 2025-01-21 | BERMAN DENNIS N | Sell | 6.67K | $3.61 | 24.07K |
| 2025-01-21 | Werner Milton H. | Sell | 45.00K | $2.16 | 97.20K |
| 2025-01-21 | BERMAN DENNIS N | Sell | 3.78K | $17.52 | 66.23K |
| 2025-01-21 | BERMAN DENNIS N | Sell | 30.00K | $1.54 | 46.20K |
| 2025-01-21 | BERMAN DENNIS N | Sell | 1.14K | $60.00 | 68.28K |
| 2025-01-21 | Werner Milton H. | Sell | 20.83K | $6.42 | 133.75K |
| 2025-01-21 | Werner Milton H. | Sell | 16.67K | $60.00 | 1.00M |
| 2025-01-21 | Werner Milton H. | Sell | 3.64K | $28.76 | 104.77K |
| 2025-01-03 | Werner Milton H. | Buy | 5.32M | $1.26 | 6.70M |
| 2025-01-03 | Werner Milton H. | Buy | 4.06M | $1.58 | 6.41M |
| 2025-01-03 | Werner Milton H. | Buy | 2.21M | $1.45 | 3.20M |
| 2025-01-03 | Lees-Rolfe Garth | Buy | 470.86K | $1.26 | 593.28K |
| 2025-01-03 | Lees-Rolfe Garth | Buy | 432.85K | $1.58 | 683.91K |
| 2025-01-03 | Lees-Rolfe Garth | Buy | 235.38K | $1.45 | 341.31K |
| 2025-01-03 | Freeman Roy Lester | Buy | 344.45K | $1.26 | 434.01K |
| 2025-01-03 | Freeman Roy Lester | Buy | 316.65K | $1.58 | 500.30K |
| 2025-01-03 | Freeman Roy Lester | Buy | 172.19K | $1.45 | 249.68K |
Latest filed quarter: Q2 2026.
Institutions holding: 107, holders +3 vs prior quarter. Ownership 67.67%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| SANDS CAPITAL ALTERNATIVES, LLC | 13.02M | 0 | 0.00% | 26.43M |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 10.88M | 0 | 0.00% | 22.08M |
| TRAILS EDGE CAPITAL PARTNERS, LP | 9.05M | 993.97K | +12.34% | 18.37M |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 8.62M | 0 | 0.00% | 17.51M |
| BLACKROCK, INC. | 7.77M | 1.46M | +23.24% | 15.77M |
| ADAR1 CAPITAL MANAGEMENT, LLC | 7.39M | 780.63K | +11.82% | 15.00M |
| BLACKSTONE INC. | 5.94M | 0 | 0.00% | 12.05M |
| SIREN, L.L.C. | 5.85M | 0 | 0.00% | 11.88M |
| COMMODORE CAPITAL LP | 5.40M | 0 | 0.00% | 10.96M |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.94M | 484.69K | +10.89% | 10.02M |
| MILLENNIUM MANAGEMENT LLC | 4.03M | 1.10M | +37.57% | 8.18M |
| SATURN V CAPITAL MANAGEMENT LP | 3.87M | 5.61K | +0.15% | 7.85M |
| KALEHUA CAPITAL MANAGEMENT LLC | 3.82M | 0 | 0.00% | 7.76M |
| SPRUCE STREET CAPITAL LP | 3.58M | 0 | 0.00% | 7.27M |
| SQUADRON CAPITAL MANAGEMENT LLC | 3.00M | -500.00K | -14.29% | 6.09M |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 2.70M | 0 | 0.00% | 5.48M |
| GEODE CAPITAL MANAGEMENT, LLC | 2.61M | 436.94K | +20.13% | 5.29M |
| STATE STREET CORP | 1.91M | 223.28K | +13.24% | 3.88M |
| SUMMITTX CAPITAL, L.P. | 1.78M | 255.73K | +16.77% | 3.61M |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 1.35M | 0 | 0.00% | 2.74M |
| NORTHERN TRUST CORP | 878.59K | 159.78K | +22.23% | 1.78M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 809.49K | 191.76K | +31.04% | 1.64M |
| TWO SIGMA INVESTMENTS, LP | 806.26K | -41.35K | -4.88% | 1.64M |
| SPHERA FUNDS MANAGEMENT LTD. | 649.31K | 649.31K | New | 1.32M |
| VANGUARD FIDUCIARY TRUST CO | 607.26K | 40.26K | +7.10% | 1.23M |
Insights · Dividends · Forecast · Financials · Learn
$223.26M
Market Cap
-3.35
P/E
6.60
Forward P/E
68
Score